Mixed oncologic and immunologic therapy got more favorable customized Rankin Size scores at post-treatment follow-up in comparison to those receiving either oncologic or immunologic therapy alone (2 [array 14] vs 4 [array 26],p< 0
Mixed oncologic and immunologic therapy got more favorable customized Rankin Size scores at post-treatment follow-up in comparison to those receiving